We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>.
- Authors
Barley, Kevin; Sanchez, Larysa; Cho, Hearn J.; Parekh, Samir; Madduri, Deepu; Richter, Joshua; Isola, Luis; Goldstein, Talia; Dhadwal, Amishi; Zarychta, Katarzyna; Sanchez, Gillian Morgan; Catamero, Donna; Verina, Daniel; Florendo, Erika; Yum, Moon‐hee; La, Lisa; Gullie, Jude; Chan, Elaine; Jagannath, Sundar; Chari, Ajai
- Publication
American Journal of Hematology, 2020, Vol 95, Issue 2, pE51
- ISSN
0361-8609
- Publication type
Article
- DOI
10.1002/ajh.25695